Find and Pitch Jounalists, Get Your Story Covered

Tags: cisplatin,cisplatin-based chemotherapy,testicular cancer,cervical cancer,hearing loss breast cancer lung cancer multiple myeloma myeloma

	Profile	Recent Articles on Subject
1	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: Jazz Pharmaceuticals to acquire Chimerix and its experimental brain cancer drug - about 1 month ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Keytruda Not Cost-Effective in Locally Advanced Cervical Cancer, Study Says - about 1 month ago Adding Radioligand to Enzalutamide Boosts OS in Metastatic CRPC - about 2 months ago New First-Line Option for Advanced ALK-Positive Lung Cancer - 4 months ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 7 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 7 months ago Trial Questions Role of Dual Immunotherapy in First-Line NSCLC - 8 months ago Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT - 9 months ago Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer - about 1 year ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - about 1 year ago First-Line Nivolumab Plus Chemo Approved for Bladder Cancer - about 1 year ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - about 1 year ago Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results - about 1 year ago New First-Line Option for Pancreatic Cancer Approved - about 1 year ago Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBC - over 1 year ago Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCC - over 1 year ago
3	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Dual Immunotherapy Shows Promise in MSI-H/dMMR Metastatic Colorectal Cancer - 2 months ago High-Dose Vitamin C Improves Outcomes for Late-Stage Pancreatic Cancer - 4 months ago New Study Assesses Ifinatamab Deruxtecan for Treatment of Small Cell Lung Cancer - 8 months ago FDA Approves Durvalumab Plus Chemotherapy to Treat Endometrial Cancer - 10 months ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - about 1 year ago Novel Chemotherapy Method Could Decrease Lung Cancer Tumor Size - about 1 year ago FDA Approves Irinotecan Liposome for Metastatic Pancreatic Adenocarcinoma - about 1 year ago
4	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Adding Palbociclib to Standard Care Improved PFS in Triple-Positive Breast Cancer - 3 months ago Sequencing in Advanced Urothelial Carcinoma - 5 months ago KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - over 1 year ago Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer - over 1 year ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Tislelizumab in Combination With Chemotherapy for Gastric, Gastrosophageal Junction Adenocarcinoma - 3 months ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - about 1 year ago Pembrolizumab, Chemoradiotherapy Meet Overall Survival Endpoint for Cervical Cancer - about 1 year ago FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - over 1 year ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - over 1 year ago Datopotamab Deruxtecan Demonstrates Improvement in Progression-Free Survival in HR+, HER2- Breast Cancer - over 1 year ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 7 months ago FDA Approves Axatilimab-csfr for cGVHD - 8 months ago FDA Approves Tislelizumab-jsgr for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy - about 1 year ago Phase 3 Study Supports Pembrolizumab Plus Lenvatinib as Standard of Care in Patients With Advanced Endometrial Cancer Who Received Prior Platinum Therapy - over 1 year ago
7	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 7 months ago STAT+: Results on Novartis prostate cancer therapy could expand its use - over 1 year ago
8	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Navigating Oncology Drug Shortages: Ethical Frameworks and Strategic Management - 10 months ago
9	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 11 months ago
10	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA Approves New Frontline Regimen for Aggressive ALL - about 1 year ago

Journalists covering cisplatin